CONMED Corp — Director's Dealing 2017

Mar 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2017-03-01

Reporting Person: Hartman Curt R (President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-01	Common Stock	M	1950	—	Acquired	30736	Direct
2017-03-01	Common Stock	F	696	$41.93	Disposed	30040	Direct
2017-03-01	Common Stock	M	2250	—	Acquired	32290	Direct
2017-03-01	Common Stock	F	820	$41.93	Disposed	31470	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-01	Rsus (restricted Stock Units)	$0	M	1950	Disposed	2025-02-27	Common Stock (1950)	Direct
2017-03-01	Rsus (restricted Stock Units)	$0	M	2250	Disposed	2026-03-01	Common Stock (2250)	Direct
2017-03-01	Options To Purchase Common Stock	$41.93	A	159150	Acquired	2027-03-01	Common Stock (159150)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2006 Stock Incentive Plan and generally vest in equal amounts (25%) over a four year period.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

F3: The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period